InvestorsHub Logo
Followers 58
Posts 10142
Boards Moderated 1
Alias Born 09/21/2016

Re: XenaLives post# 135291

Tuesday, 12/26/2017 4:50:29 AM

Tuesday, December 26, 2017 4:50:29 AM

Post# of 462121

Xena
Then perhaps Parkinson's abroad is a good idea. Maybe we need to go forward with AU Alzheimer's if the U.S. won't take action, maybe include the Japanese too. There are alternative.



Someone has to break the mold b/c the current new product introduction/FDA trials process clearly does not meet our patients needs. IMO, Dr. M. saw the PD off shore trails as a rational and effective alternative. I am not a big conspiracy guy but something is fundamentally wrong when the only people who can afford to complete the FDA trials approval process are the BP competition. Alternatively, if A2-73 was evaluated and prioritized for trials approval based on peer/academic/P1 (PD/MS-effectiveness potential) then we have a balanced process. If A2-73 blows the doors off anything BIIB has in the chute then why isn't the FDA or someone like them stepping in to advocate evaluate and define an alternative process for MS accelerated testing? Same ol, same ol.....money talks.

IMO, breakthrough trial should not be controlled or managed by a regulatory body. If they fail then you have the answer, but if they show promise the priorities are self assigned.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News